On May 8, 2023, in order to strengthen the friendly exchange and win-win cooperation, Mr. Jung Byung-ho, the president of WCA Korea, visited Tai Aipeptide Group, and Mr. Fu Qiang, the director of International Business Division, warmly received and accompanied the visit. This exchange not only helps Tai Aipei Group to further develop foreign markets, but also is a new starting point for future friendship and cooperation between the two sides!
United World Chinese Association is a non-political and non-religious global organization. It has 6 million members in more than 180 countries and regions, and is the largest Chinese civil organization in the world. The Association takes “peace, friendship, development and win-win” as its tenet, “filial piety before righteousness and righteousness before profit” as its code of conduct, and always practices respect for the elderly and the virtuous, honest management and morality, and has gathered the strength of more than 50 million overseas Chinese around the world.
Accompanied by Director of International Business Division Mr. Fu Qiang, he visited the exhibition hall of Tai Aipei Biotechnology and learned in detail about the group’s overview, production process, technical advantages, production capacity, social responsibility and the group’s future development strategy model. After the visit, Mr. Zheng Binghao understood the peptide production technology and product advantages of the group, and highly evaluated the production management and quality control, and gave affirmation and appreciation to TAIPEI.
Mr. Jung Byung-ho thinks that TAIPEI is a high-tech enterprise with the strength of scientific and technological innovation and active social responsibility, to bring the small molecule peptide to Korea, to radiate the world, and to integrate into the international market. We believe in TAIPEI, so that small molecule peptide products can play a bigger role in the field of big health.
So far, this visit and exchange activity was successfully concluded. Tai Aipeptide Group always responds to the call of national policy, insists on the strategy of people-oriented sustainable development, builds the leading brand in the industry, insists on customer-focused, high-quality service, realistic and innovative, and establishes a good social image of the industry. In the future, Tai Aipeptide Group will continue to adhere to the development goal of “being a century enterprise in the health industry and serving 100 million families in 2030″, strive to play its own advantages, integrate global resources, provide customers with high quality peptide products, serve the large domestic cycle, and at the same time, let the high quality products “go out” to a wider area. “to a broader international market!
Post time: May-08-2023